Sick Celebrities

Celebrities

Paul Allen diagnosed with non-Hodgkin’s lymphoma

david

Considered one of the world’s leading entrepreneurs, Allen co-founded Microsoft with Bill Gates in 1975. Now one of the wealthiest men in the world with an estimated net worth of approximately $10.5 billion, Allen spearheads many corporations and continues to create and oversee multiple technological projects the world over.

Allen, 56, while more than successful in his career, has had to endure several pitfalls in regards to his health. He was diagnosed with non-Hodgkin’s Lymphoma sometime earlier this month, it was reported.

Non-Hodgkin’s Lymphoma occurs in the white blood cells of the body, known as lymphocytes. Lymphocytes are the body’s defense mechanism and help fight diseases and infections. In non-Hodgkin’s Lymphoma, these white blood cells are produced uncontrollably and build tumors. Allen is reportedly suffering from B-cell lymphoma.

NHL is a life-threatening disease, and while its cause is still unknown, it has been confirmed that Paul Allen has begun chemotherapy.

According to The Huffington Post, Paul’s sister Jody sent a memo to employees of Vulcan Inc., of which Paul is chairman. In the memo, it says he remains “upbeat” and is confident he can beat his illness.

This is not the first time Allen has had to battle cancer. Diagnosed with Hodgkin’s Disease (also known as Hodgkin’s Lymphoma) in 1983, Allen underwent radiotherapy and received a bone marrow transplant. He successfully beat the cancer after being in treatment for several months.

Hodgkin’s disease is a type of cancer that occurs in the body’s white blood cells, which are also known an lymphocytes. The cancer spreads from one lymph node to another, but has been found to respond to radiation therapy treatment. An estimated 90 percent of patients who are diagnosed with this disease in its early stages will survive.

Find out more about Hodgkin’s Disease and non-Hodgkin’s lymphoma.

Image: http://commons.wikimedia.org/wiki/File:Paull_Allen_fix_1.JPG,

Author: Michael Sprague

Tags:
Back to top